shareholding

The University has sold 4.3 million shares in one of its most successful spin-out companies, Oncimmune, raising over £5 million to invest in research and teaching. Oncimmune was founded on Professor John Robertson’s research, based in the Faculty of Medicine and Health Services. Following Robertson’s research project, Oncimmune developed...